ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Maximizing Site Performance: The Hidden Benefits Of Unified eConsent And EDC

  Disconnected systems for eConsent and EDC create inefficiencies that burden clinical trial teams, but modern integrated platform solutions are streamlining operations.

• Top 5 Dos And Don'ts Of RTSM

  Discover best practices and common pitfalls for sponsors and vendors in RTSM as well as how to optimize your study by leveraging vendor expertise, avoiding delays, and embracing innovation.

• Proven Process For Managing Clinical Trial Changes, Data Migrations

  Explore how the Imperial College London was able to complete a successful migration of 14 ongoing studies, involving over 1,700 patients and 150,000+ forms, within a 16-month timeframe.

• Endpoint Reliability And eCOA Solutions Facilitate CNS Trial Success

  A Japan-based pharmaceutical development company utilized Signant's eCOA solutions and knowledge to ensure the reliability of endpoints in their Phase 3 and extended-duration CNS trials.

• Can Your Clinical Trial Design Handle Mid-Study Changes?

  Mid-study changes are frequently inevitable, but it’s possible to reduce the downtime they create with strategic planning and technology. See how to plan for mid-study changes that mitigate downtime.

• It's Official: CRIO Sites Are Now 25% Of US Sites On Chronic Condition Studies

  CRIO continues to lead the U.S. eSource market, with its platform widely adopted across clinical research sites. A recent analysis of 50 Phase 2 and 3 studies showed that, on average, 28% of U.S. sites were CRIO clients, with even higher adoption in key therapeutic areas.

• Digital Advancements In Clinical Development - What's Next?

  Review this year's predictions for improving digital biomarkers and data analytics, bettering endpoint sensitivity and specificity, and reducing timelines and costs of clinical development.

• eCOA Risk Management In The Digital Age

  Regulators across the globe are urging the industry to strengthen their data integrity practices. This article addresses the additional considerations that go hand in hand with the increased reliance on eSource data and the expansion of the electronic systems in clinical trials.

• How Small And Mid-Sized Biopharmaceutical Companies Can Easily Achieve Digital Innovation For Their Clinical Data

  Discover how forward- thinking life science companies are defining their vision and looking for like-minded partners to execute information technology.

• Leveraging Empowered Patients To Build Better Clinical Registries

  Uncover the potential of decentralized, patient-centric approaches in enhancing the efficiency and effectiveness of clinical trials and specifically, the creation of public or closed patient registries.